Navigation Links
35th ESMO Congress media alert
Date:8/9/2010

Cancer is a leading cause of mortality worldwide, accounting for more than one in ten deaths. By 2030, the global burden is expected to exceed 12 million. The ESMO Congress provides a major international forum for the presentation of new research on the treatment of cancer

Congress Program Highlights

  • New findings from major Phase III trials, potentially practice changing
  • Promising new drugs to treat ovarian, skin, colorectal and other cancers
  • New hormonal agents in advanced prostate cancer
  • Personalized medicine: do ethnic differences matter?
  • Progress in the treatment of advanced colorectal cancer
  • Prevention and management of toxicity and other side-effects in targeted therapies
  • How proteomic profiling can guide therapy selection
  • The importance of conducting well-designed clinical trials
  • Combining chemotherapy and radiotherapy in small cell lung cancer
  • New developments in targeted therapies for lung cancer
  • MicroRNAs: the new genes involved in cancer
  • European disparities in cancer control
  • More than 200 presentations; more than 300 international experts
  • Late-breaking abstracts: the latest studies with new findings
  • NEW! Multidisciplinary Interactive Sessions (MIS): experts will present treatment options from the perspective of different disciplines within a multidisciplinary team.
  • Controversy sessions: five lively discussions on particularly hot topics based on latest research results.
  • Keynote Lectures: three important presentations in the field of basic science and translational research, the new frontier in cancer research.
  • The seventh batch of ESMO Designated Centers of Integrated Oncology and Palliative Care will be announced as centers of excellence for patient care in Europe.
  • A session on the newly released ESMO Clinical Practice Guidelines: the best standards of cancer care with improved methodology.
  • Oncology Highlights of the most important advances in cancer treatment in 2010.
  • The 8th ESMO Patient Seminar where patients will have the chance to meet oncologists and hear about the conditions of cancer treatment in Europe, discuss and confront doctors about the consequences of cancer therapy, learn the approaches to long-term survivorship and the future perspective of cancer treatments.

The conference full program is available at http://www.esmo.org/events/milan-2010-congress/program.html

Meeting venue

The 35th ESMO Congress will take place at Fiera Milano Congressi, (viale Scarampo,20145 Milan, Italy), easily accessible by public transportation. You can take Metro line 1 (red) --direction to Rho Fiera, stop at Lotto Fieramilanocity station. Follow the Exit 'via Vigliani'.

Appointments for the Media

Friday, 8 October 2010

Opening Press Conference
12:00-13:00, Press Conference Room (Asia Room)

Saturday, 9 October 2010

Press Briefing Day 1
8:15-9:00, ESMO Press Conference Room (Asia Room)
Gynaecological cancers, Chest tumours, Palliative Care

Round-table
12:00-12:45, Press Conference Room (Asia Room)
Topic to be confirmed

Sunday, 10 October 2010

Press Briefing Day 2
8:15-9:00, Press Conference Room (Asia Room)
Breast cancer, Neuro-oncology, Hematological malignancies

Press Conference
12:15-13:00, Press Conference Room (Asia Room)
Topic to be confirmed

Monday, 11 October 2010

Press Briefing Day 3
8:15-9:00, Press Conference Room (Asia Room)
Breast cancer, Chest tumours, Gynaecological cancers

Round-table
12:15-13:00, Press Conference Room (Asia Room)
Topic to be confirmed

The full Media Program will be available early September after the final outcome of late-breaker submissions. Frequent updates will be published on the ESMO Online Newsroom

A fully equipped press room will be in operation at the Congress with Internet access (wired and wireless) and telephone lines for registered reporters.

In addition to attending media events, registered journalists will also have access to all congress sessions and the possibility to schedule one-on-one interviews with top speakers, presenters of the studies and ESMO key opinion leaders, both in presence and remotely. Please contact the ESMO Press Office at media@esmo.org to pre-book your interviews.

Media registration

To register for the congress as a media representative, please visit www.esmo.org/newsroom/resources and send the Complimentary Media Registration form to the ESMO Press Office within Tuesday, 31 August to benefit from pre-registration. On-site registration will be possible at the Press Registration Desk.

Accommodation

AIM Group-AIM Dmc has been appointed by ESMO to manage hotel accommodation in relation to the 35th ESMO Congress. For hotel reservation, please visit: http://www.esmo.org/events/milan-2010-congress/accommodation.html


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Related biology news :

1. Biologists meet with members of Congress
2. The biology of fungi -- 1.5 million species -- 1 congress
3. NY state the focus of Congressional hearing on how research and innovation fuel local economies
4. 3rd Baltic Congress of Osteoporosis to take place in Riga
5. New FRAX tools launched at World Congress on Osteoporosis
6. Winner of Pierre Delmas Prize announced at World Congress on Osteoporosis 2010
7. Congress takes another stride toward public access to research
8. Record number of abstracts received for the World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
9. World Congress on Osteoporosis 2010 -- IOF WCO -- ECCEO10
10. World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
11. Register now online for the World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/8/2016)... March 8, 2016   Valencell , the ... announced it has secured $11M in Series D ... a new venture fund being launched by UAE-based ... from existing investors TDF Ventures and WSJ Joshua ... continue its triple-digit growth and accelerate its pioneering ...
(Date:3/3/2016)... SOTO, Kansas , March 3, 2016 ... Oncimmune,s Early CDT®-Lung, a blood test to aid ... cancer Early CDT®-Lung test to its clients ... Early CDT®-Lung test to its clients which include ... a leader in early cancer detection, today announced a ...
(Date:3/1/2016)... 1, 2016 ... of the  "Global Biometric Access Control ... their offering. --> http://www.researchandmarkets.com/research/ghsgdt/global_biometric ... the  "Global Biometric Access Control Systems ... offering. --> Research and ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... ... April 27, 2016 , ... Global Stem Cells Group CEO ... is the founder of GSCG affiliate Kimera Labs in Miami. , In 2004, Ross ... stem cell transplantation for hematologic disorders and the suppression of graft vs. host disease ...
(Date:4/26/2016)... ... April 27, 2016 , ... ... Rothgerber Christie LLP as an associate in the firm’s Intellectual Property practice group. ... mechanical and electromechanical patent applications. He has an electrical engineering and computer engineering ...
(Date:4/26/2016)... ... April 26, 2016 , ... Mr. Palmer created the RPO ... the first multi-million dollar, multi-year managed services contract in the U.S. intelligence community with ... our leadership team,” said John Younger, founder of Accolo. “We are growing and ...
(Date:4/26/2016)... and MIAMI , ... prize recognizes the innovation capabilities of Norma,s R&D ... benefit patients and laboratory diagnostics globally. ... Norma Instruments , an innovative technology ... the field of hematology, announced today that it ...
Breaking Biology Technology: